UFP Technologies, Inc. (UFPT)
305.06
-0.85
(-0.28%)
USD |
NASDAQ |
Nov 13, 16:00
305.30
+0.24
(+0.08%)
Pre-Market: 19:59
UFP Technologies Net Income (Quarterly) : 20.62M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.62M |
| June 30, 2026 | 20.85M |
| March 31, 2026 | 17.50M |
| December 31, 2025 | 17.57M |
| September 30, 2025 | 16.38M |
| June 30, 2025 | 17.18M |
| March 31, 2025 | 17.18M |
| December 31, 2024 | 16.38M |
| September 30, 2024 | 16.36M |
| June 30, 2024 | 13.55M |
| March 31, 2024 | 12.69M |
| December 31, 2023 | 11.61M |
| September 30, 2023 | 11.69M |
| June 30, 2023 | 11.88M |
| March 31, 2023 | 9.739M |
| December 31, 2022 | 8.462M |
| September 30, 2022 | 19.54M |
| June 30, 2022 | 8.929M |
| March 31, 2022 | 4.858M |
| December 31, 2021 | 3.218M |
| September 30, 2021 | 3.789M |
| June 30, 2021 | 4.715M |
| March 31, 2021 | 4.163M |
| December 31, 2020 | 4.172M |
| September 30, 2020 | 2.988M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.318M |
| March 31, 2020 | 3.891M |
| December 31, 2019 | 5.777M |
| September 30, 2019 | 5.641M |
| June 30, 2019 | 4.598M |
| March 31, 2019 | 3.734M |
| December 31, 2018 | 4.41M |
| September 30, 2018 | 4.134M |
| June 30, 2018 | 3.99M |
| March 31, 2018 | 1.777M |
| December 31, 2017 | 2.715M |
| September 30, 2017 | 1.695M |
| June 30, 2017 | 2.63M |
| March 31, 2017 | 2.171M |
| December 31, 2016 | 1.491M |
| September 30, 2016 | 2.669M |
| June 30, 2016 | 2.735M |
| March 31, 2016 | 1.075M |
| December 31, 2015 | 1.676M |
| September 30, 2015 | 1.992M |
| June 30, 2015 | 2.272M |
| March 31, 2015 | 1.653M |
| December 31, 2014 | 1.571M |
| September 30, 2014 | 2.066M |
| June 30, 2014 | 1.86M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 141.17M |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
| AtriCure, Inc. | 4.064M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 172.43M |
| Total Expenses (Quarterly) | 151.82M |
| EPS Diluted (Quarterly) | 2.641 |
| Enterprise Value | 2.459B |
| Gross Profit Margin (Quarterly) | 29.44% |
| Profit Margin (Quarterly) | 11.96% |
| Earnings Yield | 3.22% |
| Operating Earnings Yield | 4.21% |
| Normalized Earnings Yield | 3.203 |